Feasibility Studies

Medherant offers rapid evaluation of the suitability of drugs for formulation with its TEPI Patch^® technology by determining their compatibility with its adhesives, formulating prototype patches and then testing them against a predetermined target release profile.

We’rMedherant’s formulation team are able to create a short-list of candidate formulations in just 3 months and then go on to complete proof-of-concept studies with formulations that meet your target product profile using our in-house formulation & small-scale non-GMP manufacturing capability.